CMR assessed maladaptive right ventricular remodelling predicts treatment failure in pulmonary arterial hypertension

Z. Goh (Sheffield, United Kingdom), N. Balasubramanian (Sheffield, United Kingdom), S. Alabed (Sheffield, United Kingdom), K. Dwivedi (Sheffield, United Kingdom), Y. Shahin (Sheffield, United Kingdom), A. Mk Rothman (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), A. Thompson (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), J. M Wild (Sheffield, United Kingdom), C. S Johns (Sheffield, United Kingdom), R. A Lewis (Sheffield, United Kingdom), R. Gosling (Sheffield, United Kingdom), M. Sharkey (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. G Kiely (Sheffield, United Kingdom), A. J Swift (Sheffield, United Kingdom)

Source: International Congress 2022 – Risk assessment in pulmonary arterial hypertension
Session: Risk assessment in pulmonary arterial hypertension
Session type: Thematic Poster
Number: 470

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Goh (Sheffield, United Kingdom), N. Balasubramanian (Sheffield, United Kingdom), S. Alabed (Sheffield, United Kingdom), K. Dwivedi (Sheffield, United Kingdom), Y. Shahin (Sheffield, United Kingdom), A. Mk Rothman (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), A. Thompson (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), J. M Wild (Sheffield, United Kingdom), C. S Johns (Sheffield, United Kingdom), R. A Lewis (Sheffield, United Kingdom), R. Gosling (Sheffield, United Kingdom), M. Sharkey (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. G Kiely (Sheffield, United Kingdom), A. J Swift (Sheffield, United Kingdom). CMR assessed maladaptive right ventricular remodelling predicts treatment failure in pulmonary arterial hypertension. 470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.